Literature DB >> 3964762

Pathogenesis of precirrhotic portal hypertension in alcohol-fed baboons.

H Miyakawa, S Iida, M A Leo, R J Greenstein, D S Zimmon, C S Lieber.   

Abstract

To study mechanisms and anatomic correlates of precirrhotic portal hypertension, we measured portal pressure either at laparotomy (in the portal vein) or by hepatic vein catheterization (wedge pressure) in 24 pairs of baboons fed 50% of energy either as ethanol or isocaloric carbohydrate (controls) for 4 mo-9 yr. On liver biopsy 7 had simple fatty liver; none had portal pressure exceeding the control range (2.7-13.0 cmH2O). The remaining 17 alcohol-fed baboons had fibrous tissue deposition around the terminal hepatic venules and adjacent sinusoids. The mean portal pressure was significantly increased (15.0 +/- 1.4 cmH2O) compared with the value in baboons with fatty liver (9.6 +/- 0.9 cmH2O) and in controls (8.0 +/- 0.6 cmH2O), with 8 animals exceeding the control range. Estimated hepatic blood flow was unchanged. Alcohol feeding resulted in increased hepatocyte size in both the fatty liver and fatty liver with fibrosis group; however, portal pressure did not correlate with alterations of cell size, liver volume, hepatic triacylglycerol, and protein contents. By contrast, for veins of comparable size, there was a significant correlation (r = 0.6666, p less than 0.01) between the thickness of the perivenular fibrous rim and portal pressure. Perivenular fibrosis was commonly associated with adjacent perisinusoidal fibrosis and this lesion also correlated with portal pressure. Furthermore, if one postulates that increased cell size causes enhanced pressure with secondary fibrosis, the latter should have first occurred "upstream," in the mid and portal zones. Sequential biopsy specimens, however, showed that fibrosis first appeared in the perivenular areas, suggesting that, in most instances, increased pressure is in fact secondary to the perivenular fibrosis.

Entities:  

Mesh:

Year:  1985        PMID: 3964762     DOI: 10.1016/s0016-5085(85)80146-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Portal hypertension in chronic hepatitis: relationship to morphological changes.

Authors:  D J van Leeuwen; S C Howe; P J Scheuer; S Sherlock
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

2.  The sinusoidal barrier in alcoholic patients without liver fibrosis. A morphometric study.

Authors:  F Sztark; P Latry; A Quinton; C Balabaud; P Bioulac-Sage
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

Review 3.  The pathogenesis of alcoholic liver disease.

Authors:  R Goldin
Journal:  Int J Exp Pathol       Date:  1994-04       Impact factor: 1.925

Review 4.  The hepatic extracellular matrix. I. Components and distribution in normal liver.

Authors:  A Martinez-Hernandez; P S Amenta
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

5.  Spleen enlargement in patients with nonalcoholic fatty liver: correlation between degree of fatty infiltration in liver and size of spleen.

Authors:  Y Tsushima; K Endo
Journal:  Dig Dis Sci       Date:  2000-01       Impact factor: 3.199

6.  Development of risky varices in alcoholic cirrhosis with a well-maintained nutritional status.

Authors:  Hirayuki Enomoto; Yoshiyuki Sakai; Yoshinori Iwata; Ryo Takata; Nobuhiro Aizawa; Naoto Ikeda; Kunihiro Hasegawa; Chikage Nakano; Takashi Nishimura; Kazunori Yoh; Akio Ishii; Tomoyuki Takashima; Hiroki Nishikawa; Hiroko Iijima; Shuhei Nishiguchi
Journal:  World J Hepatol       Date:  2015-09-28

7.  Relationship between degree of portal hypertension and liver histologic lesions in patients with alcoholic cirrhosis. Effect of acute alcoholic hepatitis on portal hypertension.

Authors:  T Poynard; C Degott; C Munoz; D Lebrec
Journal:  Dig Dis Sci       Date:  1987-04       Impact factor: 3.199

8.  Insulin Production and Resistance in Different Models of Diet-Induced Obesity and Metabolic Syndrome.

Authors:  Salamah M Alwahsh; Benjamin J Dwyer; Shareen Forbes; David H van Thiel; Philip J Starkey Lewis; Giuliano Ramadori
Journal:  Int J Mol Sci       Date:  2017-01-28       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.